GTSE1 and central nervous system cancer: These results indicate that high expression of GTSE1, TROAP, IQGAP3, KIF23, HJURP, ASPM, MIKI67, KIF20A, FAM64A, and KIF2C might be unfavorable for glioma prognosis, whereas high expression of LDHD, ETNPPL, SCN2B, MRVI1, NEBL, ADARB2, FBXW4, CBX7, LYNX1, and SPOCK2 may be beneficial for the prognosis of glioma.